Contraceptive Technology Update – August 1, 2008
August 1, 2008
View Issues
-
Seek new avenues to raise chlamydia screenings among adolescent women
With recent findings that 4% of young women between the ages of 14 and 19 in the United States are infected with chlamydia, public health officials are stepping up efforts to screen more adolescent girls for the sexually transmitted disease (STD). -
Answer question: 'How to prevent chlamydia?'
What can you tell teens about preventing chlamydia? Check the following information from the Centers for Disease Control and Prevention (CDC): -
Keeping OC users on track: What works?
The next patient in your office is a 25-year-old mother of two. She's using oral contraceptives (OCs) for birth control, but when you ask her about her method use, she admits she's having problems remembering to take her daily pill. -
Pill with dienogest progestin under review
Research is eyeing an oral contraceptive (OC) formulation with a new progestin: dienogest. Results of an efficacy trial, presented at the 2008 Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG), indicate the formulation is effective, safe, and well tolerated. -
New review focuses on emergency contraception
When it comes to emergency contraception (EC), what does your clinic offer? A new review has found that mifepristone is the most effective EC method to prevent unwanted pregnancy; however, the drug has not gained U.S. regulatory approval for that use. -
Use new screening tool for menstrual migraine
The woman in your exam room says she has severe headaches that usually begin about two days before her menstrual cycle. When they occur, they get more severe in intensity. She does not report any signs of neurological aura, such as flashing lights or tingling sensations, with the headaches. What's your diagnosis? -
Washington Watch: Universal coverage looms large in U.S.
With high and rising levels of uninsurance and health care costs, federal and state policy-makers have taken note. -
CT Updates: Sign up now for annual conference
Circle the dates on your calendar for Reproductive Health 2008, the annual meeting for the Association of Reproductive Health Professionals (ARHP), Planned Parenthood Federation of America, and the Society of Family Planning. The meeting is scheduled for Sept. 17-20 in Washington, DC. -
STD Quarterly: More education is needed to boost HPV vaccination rates in preteen girls, CDC says
When it comes to administering the vaccine for human papillomavirus (HPV), providers are following the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices' recommendation to target all girls ages 11-12 for routine vaccination. -
STD Quarterly: News Briefs: Get HPV vaccine dose replacements via plan
Have you administered the initial dose of Gardasil, the quadrivalent human papillomavirus (HPV) vaccine, to a young woman with private insurance, only to later discover that her policy does not cover vaccine reimbursement?